From: ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies
Control | PD | DLB | p value | |
---|---|---|---|---|
Sex (M:F) | 6:6 | 7:4 | 7:4 | 0.68+ |
Age (years) | 77 ± 10 (62–92) | 78 ± 6 (71–88) | 78 ± 6 (67–88) | 0.94∆ |
PMD (hours) | 21 ± 11 (6–36) | 13 ± 7 (3–23) | 24.5 ± 12 (4–39) | 0.07∆ |
Duration (years) | - | 19 ± 8 (8–36) | 7 ± 4 (1–13) | <0.001 |
Braak PD stage # | - | 9 IV; 2 V/VI | 0 IV; 11 V/VI | <0.001+ |
NIA Regan AD * | 0/12 | 0/11 | 1/11 | 0.37+ |
CDR | 0.0 ± 0.1 (0–0.5) | 0.1 ± 0.2 (0–0.5) | 2.4 ± 0.8 (1–3)# | <0.001+ |
Aβ42 (μg/ml) ^ | 13 ±8 (7.4-24.9) | 16.5 ± 10 (7.0-31.1) | 31.4 ± 11(17.8-42.3) # | 0.046∆ |